DDX3, a potential target for cancer treatment

Por Bol, Guus Martinus, Xie, Min, Raman, Venu
Publicado no Mol Cancer (2015)

PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3

Por Bol, Guus Martinus, Khan, Raheela, van Voss, Marise Rosa Heerma, Tantravedi, Saritha, Korz, Dorian, Kato, Yoshinori, Raman, Venu
Publicado no Cancer Chemother Pharmacol (2015)

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3

Por Xie, Min, Vesuna, Farhad, Botlagunta, Mahendran, Bol, Guus Martinus, Irving, Ashley, Bergman, Yehudit, Hosmane, Ramachandra S., Kato, Yoshinori, Winnard, Paul T., Raman, Venu
Publicado no Oncotarget (2015)